Anti‐tumor effects of PIM / PI 3K/ mTOR triple kinase inhibitor IBL ‐302 in neuroblastoma
Abstract
Article16 July 2019Open Access Source DataTransparent process Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma Sofie Mohlin Corresponding Author [email protected] orcid.org/0000-0002-2458-3963 Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden Search for more papers by this author Karin Hansson Department of Laboratory Medicine, Translational Cancer Research, Lund University...
Paper Details
Title
Anti‐tumor effects of PIM / PI 3K/ mTOR triple kinase inhibitor IBL ‐302 in neuroblastoma
Published Date
Jul 16, 2019
Journal
Volume
11
Issue
8
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History